These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 25941104)

  • 1. A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence.
    Buckley JS; Salpeter SR
    Drugs Aging; 2015 Jun; 32(6):453-67. PubMed ID: 25941104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials.
    Kim DH; Brown RT; Ding EL; Kiel DP; Berry SD
    J Am Geriatr Soc; 2011 Jun; 59(6):1019-31. PubMed ID: 21649634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.
    Wang HF; Yu JT; Tang SW; Jiang T; Tan CC; Meng XF; Wang C; Tan MS; Tan L
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):135-43. PubMed ID: 24828899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.
    Kavirajan H; Schneider LS
    Lancet Neurol; 2007 Sep; 6(9):782-92. PubMed ID: 17689146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.
    Standridge JB
    Clin Ther; 2004 May; 26(5):615-30. PubMed ID: 15220008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease.
    Schmidt R; Hofer E; Bouwman FH; Buerger K; Cordonnier C; Fladby T; Galimberti D; Georges J; Heneka MT; Hort J; Laczó J; Molinuevo JL; O'Brien JT; Religa D; Scheltens P; Schott JM; Sorbi S
    Eur J Neurol; 2015 Jun; 22(6):889-98. PubMed ID: 25808982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for cognitive impairment in older adults: A systematic review for the U.S. Preventive Services Task Force.
    Lin JS; O'Connor E; Rossom RC; Perdue LA; Eckstrom E
    Ann Intern Med; 2013 Nov; 159(9):601-12. PubMed ID: 24145578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis.
    Kennedy RE; Cutter GR; Fowler ME; Schneider LS
    JAMA Netw Open; 2018 Nov; 1(7):e184080. PubMed ID: 30646339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
    Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
    J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns and determinants of dementia pharmacotherapy in a population-based cohort of home care clients.
    Maxwell CJ; Vu M; Hogan DB; Patten SB; Jantzi M; Kergoat MJ; Jetté N; Bronskill SE; Heckman G; Hirdes JP
    Drugs Aging; 2013 Jul; 30(7):569-85. PubMed ID: 23605786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.
    Burns A; O'Brien J; ; Auriacombe S; Ballard C; Broich K; Bullock R; Feldman H; Ford G; Knapp M; McCaddon A; Iliffe S; Jacova C; Jones R; Lennon S; McKeith I; Orgogozo JM; Purandare N; Richardson M; Ritchie C; Thomas A; Warner J; Wilcock G; Wilkinson D;
    J Psychopharmacol; 2006 Nov; 20(6):732-55. PubMed ID: 17060346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.
    Emre M; Tsolaki M; Bonuccelli U; Destée A; Tolosa E; Kutzelnigg A; Ceballos-Baumann A; Zdravkovic S; Bladström A; Jones R;
    Lancet Neurol; 2010 Oct; 9(10):969-77. PubMed ID: 20729148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
    Tariot PN
    J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuation versus discontinuation of treatment for severe dementia: randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM).
    Soler A; Amer G; Leiva A; Ripoll J; Llorente MA; Leiva A; Taltavull JM; Molina R; Llobera J
    BMC Geriatr; 2019 Apr; 19(1):101. PubMed ID: 30971215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.
    Wong CW
    Drugs Aging; 2016 Jul; 33(7):451-60. PubMed ID: 27154396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.
    Deardorff WJ; Feen E; Grossberg GT
    Drugs Aging; 2015 Jul; 32(7):537-47. PubMed ID: 26033268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.
    O'Brien JT; Holmes C; Jones M; Jones R; Livingston G; McKeith I; Mittler P; Passmore P; Ritchie C; Robinson L; Sampson EL; Taylor JP; Thomas A; Burns A
    J Psychopharmacol; 2017 Feb; 31(2):147-168. PubMed ID: 28103749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness: cholinesterase inhibitors and memantine in vascular dementia.
    Wong CL; Bansback N; Lee PE; Anis AH
    Can J Neurol Sci; 2009 Nov; 36(6):735-9. PubMed ID: 19960752
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.